All News Press Releases News 2017-09-22 08:28 Episurf Medical will exhibit at the Combined Bristol & Oxford Unicompartmental Knee Arthritis Symposium, held in Oxford, UK, on October 10 Episurf Medical (NASDAQ: EPIS B) will exhibit at the Combined Bristol & Oxford Unicompartmental Knee Arthritis Symposium held […] News 2017-09-21 12:20 Xbrane Biopharma AB: Xbrane attends Carnegie Nordic HealthCare Day in New York, 5 December Xbrane is pleased to announce its participation in Carnegie Nordic Healthcare Day in New York in collaboration with […] News 2017-09-20 07:30 Organoclick resolves upon a directed share issue of approximately SEK 40 million for financing of acquisitions and continued growth NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, […] News 2017-09-19 17:31 Organoclick intends to undertake a directed share issue for financing potential acquisitions and the company's continued growth At large demand, Serendipity Ixora may make shares available to enable greater institutional participation NOT FOR PUBLICATION, DISTRIBUTION […] News 2017-09-14 09:15 Episurf Medical’s 100th Episealer® Femoral Twin implant demonstrates rapid clinical adoption Episurf Medical (NASDAQ: EPIS B) announces the 100th implantation of the knee implant Episealer Femoral Twin, which together […] News 2017-09-13 16:06 IRRAS Strengthens Executive and Commercial Teams with Appointments of Karl-Matthias Moehlmann and Klemens Fölling LA JOLLA, Calif., LAICHINGEN, Germany and STOCKHOLM, Sept. 13, 2017 IRRAS, a commercial-stage medical technology company developing breakthrough […] News 2017-09-11 07:36 Episurf Medical AB will exhibit at The Individualized TKA, held in Antwerp, Belgium, on September 22 Episurf Medical (NASDAQ: EPIS B) will exhibit at The Individualized TKA (a meeting organized by the Belgian and […] News 2017-09-11 07:35 Episurf Medical AB will exhibit at the London Knee Meeting held in London, UK, on October 3 Episurf Medical (NASDAQ: EPIS B) will exhibit at the London Knee Meeting (recognized as one of the most […] News 2017-09-11 07:34 Xbrane confirms order of Spherotide to value of SEK 8.5 million and more than 10,000 doses sold Xbrane has confirmed an additional order of Spherotide from Pooyesh Darou, its partner in the Middle East, to […] News 2017-09-07 07:14 Episurf Medical present at Aktiedagen, held in Malmö on September 27 Episurf Medical (NASDAQ: EPIS B) will present at Aktiedagen, an investor conference held in Malmö (Kockum Fritid, Hörsalen) […] News 2017-09-07 07:13 Episurf Medical AB will exhibit at FISIC’17 held in London, UK, on September 27-28 Episurf Medical (NASDAQ: EPIS B) will exhibit at FISIC’17 (organised by renowned Fortius Group, UK’s leading private orthopaedic […] News 2017-09-06 07:29 100 patient multi-center study of the Episealer® knee implant fully recruited Episurf Medical (NASDAQ: EPIS B) today announces that a European large multi-center study with 100 Episealer patients has […] News 2017-08-31 12:30 Episurf Medical’s 50th Episealer® implant in Belgium Episurf Medical announces that the 50th implantation of the Episealer® knee implant in Belgium will take place in […] News 2017-08-31 06:46 Xbrane Biopharma releases interim report for the period April - June 2017 Xbrane Biopharma ABs interim report for the period April – June 2017 is now available on the Company’s […] News 2017-08-30 12:23 IRRAS Appoints Fredrik Alpsten as Chief Financial Officer and Deputy CEO -Mr. Alpsten will Lead the Development of IRRAS’ Global Finance Strategies- Stockholm, Sweden August 30, 2017 – IRRAS, […] News 2017-08-29 06:45 Diamorph AB (publ): Interim report second quarter 2017 Second quarter The results for the second quarter should be considered against a strong comparative in the second […] News 2017-08-25 13:19 Organoclick AB (Publ) publishes its interim report for Q2 2017 “During the second quarter our positive trend from the first quarter continued. Sales increased from SEK 17.1 million […] News 2017-08-25 06:38 Episurf Medical AB will exhibit at the 34th AGA Congress held in Munich, Germany, on September 7-9 Episurf Medical (NASDAQ: EPIS B) will exhibit at the 34th AGA Congress (Society for Arthroscopy and Joint Surgery, […] News 2017-08-22 19:38 Information about ongoing discussions and negotiations concerning out-licensing of Xbrane Biopharma AB's (Publ) products Press release 2017-08-22 In accordance with what has previously been communicated in press releases, interim reports and presentations, […] News 2017-08-22 19:30 Episurf Medical AB will exhibit at SOF 2017, held in Umeå, Sweden on August 29 - September 1 Episurf Medical AB will exhibit at SOF 2017 (Swedish Orthopaedic Society), an orthopaedic conference, held in Umeå, Sweden […] News 2017-08-18 07:49 Episurf Medical Interim Report 1 April - 30 June 2017 Second quarter 2017, compared to 2016, Group » Group net sales increased by 33% to SEK 622,897 (469,380) […] News 2017-08-16 08:27 Episurf Medical reaches milestone of 250 implants Episurf Medical (NASDAQ: EPIS B) today announces that the company has reached another milestone by planning of its 250th […] News 2017-08-10 12:39 Diamorph AB (publ) to redeem its outstanding bonds in their entirety Redemption of bonds Diamorph AB (publ) (the “ Company ”) has given notice that it is exercising its […] News 2017-07-26 12:32 Management group changes in Episurf Medical Episurf Medical (NASDAQ: EPIS B) today announces that Dan Griffiths, Head of Marketing, will leave the company during […] News 2017-07-24 08:59 Xbrane Biopharma AB: Spherotide granted Market Authorization in Iran Xbranes partner Pooyesh Darou has been granted Market Authorization for sales and marketing of Spherotide 1 month formulation […] News 2017-07-20 09:31 Episurf Medical reports brief clinical update Episurf Medical’s (NASDAQ: EPIS B) first 15 patients have now had their Episealer® implants for more than 3 […] News 2017-07-20 09:30 Episurf Medical has become an approved supplier to Spire Healthcare, one of the UK’s largest independent hospital providers Episurf Medical (NASDAQ: EPIS B) has become an approved supplier to Spire Healthcare, one of the UK’s largest […] News 2017-07-19 09:29 Another preclinical paper on the Episealer implant published Another preclinical paper has been published that again validates Episurf Medical’s (NASDAQ: EPIS B) patented cartilage repair technology […] News 2017-07-11 13:08 Case-report with clinical data of Episealer patient published A peer-reviewed report from a case-study with clinical data of an Episealer patient has been published in the […] News 2017-07-11 13:06 Episurf Medical: Dennis D. Stripe to re-assume the position as Non-executive Chairman of the Board In conjunction to the change in the leadership of Episurf Medical (NASDAQ: EPIS B) January 5 2017, Dennis […] COMPANY INFO INFO@SERENDIPITY.SE STUREPLAN 15 SE-111 45 STOCKHOLM SWEDEN PORTFOLIO COMPANIES DIAMORPH EPISURF MEDICAL ORGANOCLICK IRRAS PREMUNE SWECURE XBRANE BIOPHARMA VOFF SCIENCE Copyright All Rights Reserved © 2015